Chronic kidney disease is one of the costliest and deadliest health conditions around the world today. While maladies like heart disease gain the "lion's share" of attention, CKD has the distinction of being one of the most widespread diseases that individuals don't even know they have. In fact, it's estimated that 90% of individuals in America with CKD don't know they have it. Experts believe this number includes about 1 in three American adults.
Kidneys are necessary to remove waste from our bloodstream. And without functioning kidneys, expensive and time-consuming treatments such as dialysis or kidney transplants are often the only option.
Researchers utilize albumin ELISA and Nephrin tests when creating new pharmaceuticals and treatments. These tests, which monitor kidney function in mice, rats, sheep, and humans can provide valuable insights into treatments that help prolong the lives and enhance the outcomes of individuals with CKD.